Clinical outcome and risk stratification in Brugada syndrome

Tadashi Wada, Hiroshi Morita

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Since the first report on Brugada syndrome, various risk markers for the prediction of ventricular fibrillation (VF) in patients with Brugada syndrome have been reported. Multicenter trials reported spontaneous type 1 electrocardiogram (ECG) and disease symptoms as prognostic predictors. VF induction by programmed electrical stimulation is still controversial, and most of the studies have failed to prove its significance for the prediction of spontaneous VF episodes. In Japan, although most multicenter studies have shown that patients with type 1 ECG were at high risk, it is difficult to determine the indication for implantation of an implantable cardioverter defibrillator only based on the ECG type. Recent studies have added new risk markers, such as inferolateral early repolarization, fragmented QRS, and shorter effective refractory periods of the ventricle, in addition to type 1 ECG and symptoms. Here, we review the clinical outcome and indices reported as reliable prognostic factors of Brugada syndrome with a focus on the clinical and ECG markers for risk stratification.

Original languageEnglish
Pages (from-to)100-109
Number of pages10
JournalJournal of Arrhythmia
Volume29
Issue number2
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Brugada Syndrome
Electrocardiography
Ventricular Fibrillation
Multicenter Studies
Implantable Defibrillators
Electric Stimulation
Japan
Biomarkers

Keywords

  • Brugada syndrome
  • ECG
  • Risk stratification
  • Ventricular fibrillation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Clinical outcome and risk stratification in Brugada syndrome. / Wada, Tadashi; Morita, Hiroshi.

In: Journal of Arrhythmia, Vol. 29, No. 2, 04.2013, p. 100-109.

Research output: Contribution to journalArticle

@article{e7d37bb745dd47118b206486301d9680,
title = "Clinical outcome and risk stratification in Brugada syndrome",
abstract = "Since the first report on Brugada syndrome, various risk markers for the prediction of ventricular fibrillation (VF) in patients with Brugada syndrome have been reported. Multicenter trials reported spontaneous type 1 electrocardiogram (ECG) and disease symptoms as prognostic predictors. VF induction by programmed electrical stimulation is still controversial, and most of the studies have failed to prove its significance for the prediction of spontaneous VF episodes. In Japan, although most multicenter studies have shown that patients with type 1 ECG were at high risk, it is difficult to determine the indication for implantation of an implantable cardioverter defibrillator only based on the ECG type. Recent studies have added new risk markers, such as inferolateral early repolarization, fragmented QRS, and shorter effective refractory periods of the ventricle, in addition to type 1 ECG and symptoms. Here, we review the clinical outcome and indices reported as reliable prognostic factors of Brugada syndrome with a focus on the clinical and ECG markers for risk stratification.",
keywords = "Brugada syndrome, ECG, Risk stratification, Ventricular fibrillation",
author = "Tadashi Wada and Hiroshi Morita",
year = "2013",
month = "4",
doi = "10.1016/j.joa.2012.12.008",
language = "English",
volume = "29",
pages = "100--109",
journal = "Journal of Arrhythmia",
issn = "1880-4276",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Clinical outcome and risk stratification in Brugada syndrome

AU - Wada, Tadashi

AU - Morita, Hiroshi

PY - 2013/4

Y1 - 2013/4

N2 - Since the first report on Brugada syndrome, various risk markers for the prediction of ventricular fibrillation (VF) in patients with Brugada syndrome have been reported. Multicenter trials reported spontaneous type 1 electrocardiogram (ECG) and disease symptoms as prognostic predictors. VF induction by programmed electrical stimulation is still controversial, and most of the studies have failed to prove its significance for the prediction of spontaneous VF episodes. In Japan, although most multicenter studies have shown that patients with type 1 ECG were at high risk, it is difficult to determine the indication for implantation of an implantable cardioverter defibrillator only based on the ECG type. Recent studies have added new risk markers, such as inferolateral early repolarization, fragmented QRS, and shorter effective refractory periods of the ventricle, in addition to type 1 ECG and symptoms. Here, we review the clinical outcome and indices reported as reliable prognostic factors of Brugada syndrome with a focus on the clinical and ECG markers for risk stratification.

AB - Since the first report on Brugada syndrome, various risk markers for the prediction of ventricular fibrillation (VF) in patients with Brugada syndrome have been reported. Multicenter trials reported spontaneous type 1 electrocardiogram (ECG) and disease symptoms as prognostic predictors. VF induction by programmed electrical stimulation is still controversial, and most of the studies have failed to prove its significance for the prediction of spontaneous VF episodes. In Japan, although most multicenter studies have shown that patients with type 1 ECG were at high risk, it is difficult to determine the indication for implantation of an implantable cardioverter defibrillator only based on the ECG type. Recent studies have added new risk markers, such as inferolateral early repolarization, fragmented QRS, and shorter effective refractory periods of the ventricle, in addition to type 1 ECG and symptoms. Here, we review the clinical outcome and indices reported as reliable prognostic factors of Brugada syndrome with a focus on the clinical and ECG markers for risk stratification.

KW - Brugada syndrome

KW - ECG

KW - Risk stratification

KW - Ventricular fibrillation

UR - http://www.scopus.com/inward/record.url?scp=84882450227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882450227&partnerID=8YFLogxK

U2 - 10.1016/j.joa.2012.12.008

DO - 10.1016/j.joa.2012.12.008

M3 - Article

VL - 29

SP - 100

EP - 109

JO - Journal of Arrhythmia

JF - Journal of Arrhythmia

SN - 1880-4276

IS - 2

ER -